Quantcast

Latest Daiichi Sankyo Stories

2014-05-09 20:23:13

DUBLIN, May 10, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xrtmp7/global) has announced the addition of the "Global Biosimilars Market 2014-2018" [http://www.researchandmarkets.com/research/xrtmp7/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key...

2014-05-01 08:37:39

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sdjlqk/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this...

2014-04-18 08:22:04

PARSIPPANY, N.J., April 18, 2014 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that Ken Keller will join the company as President of its Commercial operations in the United States starting May 1, 2014. In his role, Mr. Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for Daiichi Sankyo in the U.S. "We are very pleased to welcome Ken Keller into the Daiichi Sankyo family," said Joji Nakayama, President and CEO of Daiichi...

2014-04-10 12:27:26

MUMBAI, April 10, 2014 /PRNewswire/ -- Bharat Book Bureau presents The Chinese Pharmaceuticals Market to 2024. In this report China's pharmaceutical sales growth is based on economic growth in the country: This has resulted in increased healthcare expenditure internally, and increased manufacture and export. Increasing urbanization, disposable income, aging population, health education, lifestyle diseases and government investments and initiatives for healthcare infrastructure...

2014-04-03 08:21:56

DUBLIN, Apr. 03, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zvzsf4/antibodydrug ) has announced the addition of the "Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The report entitled 'Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis' is based on the evaluation of more than 90 companies. The report...

2014-04-02 08:34:26

BUENA, N.J., April 2, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based generic topical pharmaceutical company, today announced that it has appointed Damian Finio to its Board of Directors. Mr. Finio will serve as the new Chairman of the Company's Audit Committee. The Company had announced on March 31, 2014, that Michael Hemric, a Director of the Company has resigned effective April 1, 2014, and Joyce Erony, the Company's chairperson and director, had...

2014-04-02 08:32:43

MUNICH, Germany, April 2, 2014 /PRNewswire/ -- For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared with the general population[2] Daiichi Sankyo today announced its commitment to extend the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). The extension of the registry will include a specific...

2014-03-31 08:28:47

First patient enrolled in largest planned phase 3 study evaluating a novel oral anticoagulant in non-valvular atrial fibrillation patients undergoing electrical cardioversion PARSIPPANY, N.J., March 31, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor...

2014-03-28 12:26:05

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/3vpmvj/investigation) has announced the addition of the "Investigation Report on China's Olmesartan Market, 2009-2018" [http://www.researchandmarkets.com/research/3vpmvj/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to statistics from WHO, one-third of the world's adults have high blood...

2014-03-27 12:29:46

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6x67r4/global ) has announced the addition of the "Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) 2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations. The...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related